Anticancer activity and possible mode of action of 4-O-podophyllotoxinyl 12-hydroxyl-octadec-Z-9-enoate

Lipids

Volumn 40, Issue 3, 2005, Pages 303-308

  Ma, Guoyi ^a   Khan, Shabana I ^a   Mustafa, Jamal ^a   Walker, Larry A ^a,b   Khan, Ikhlas A ^a,b  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALYSIS; CELLS; TOXIC MATERIALS; TUMORS;

ANTICANCER ACTIONS; ANTICANCER ACTIVITY; PODOPYLLTOXINS;

ESTERS;

4 O PODOPHYLLOTOXINYL 12 HYDROXYLOCTADEC 9 ENOATE; 4',6 DIAMIDINO 2 PHENYLINDOLE; DNA; DNA TOPOISOMERASE (ATP HYDROLYSING); ETOPOSIDE; PODOPHYLLOTOXIN DERIVATIVE; STEARIC ACID DERIVATIVE; TUBULIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL CYCLE; CELL DEATH; CENTRAL NERVOUS SYSTEM TUMOR; COLON CANCER; CONTROLLED STUDY; DNA CONTENT; DRUG STRUCTURE; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; KIDNEY CANCER; LEUKEMIA CELL LINE; LUNG NON SMALL CELL CANCER; MELANOMA; MICROTUBULE ASSEMBLY; OVARY CANCER; PROSTATE CANCER; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; DNA TOPOISOMERASES, TYPE II; FEMALE; HUMANS; KINETICS; MALE; OLEIC ACIDS; PODOPHYLLOTOXIN;

EID: 18244362323     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-005-1386-0     Document Type: Article

References (19)

1. Gordaliza, M., Castro, M.A., del Corral, J.M., and Feliciano, A.S. (2000) Antitumor Properties of Podophyllotoxin and Related Compounds, Curr. Pharm. Des. 6, 1811-1839.
2. Shi, Q., Chen, K.C., Morrist-Natschke, S.L., and Lee K.H. (1998) Recent Progress in the Development of Tubulin Inhibitors as Antimitotic Antitumor Agents, Curr. Pharm. Des. 4, 219-248.
3. Cragg, G., and Suffness, M. (1988) Metabolism of Plant-Derived Anticancer Agents, Pharmac. Ther, 37, 425-461.
4. Sinha, B.K., and Myers, C.E. (1984) Irreversible Binding of Etoposide (VP-16-213) to Deoxyribonucleic Acid and Proteins, Biochem. Pharmacol. 33, 3725-3728.
5. Haim, N., Nemec, J., Roman, J., and Sinha, B.K. (1987) In vitro Metabolism of Etoposide (VP-16- 213) by Liver Microsomes and Irreversible Binding of Reactive Intermediates to Microsomal Proteins, Biochem. Pharmacol. 36, 327-336.
6. Mustafa, J., Khan, S.I., Ma, G., Walker, L.A., and Khan I.A. (2004) Synthesis and Anticancer Activities of Fatty Acid Analogs of Podophyllotoxin, Lipids 39, 167-172.
7. Boyd, M.R., and Paull, K.D. (1995) Some Practical Considerations and Applications of the National Cancer Institute in vitro Anticancer Drug Discovery Screen, Drug Devel. Res. 34, 91-109.
8. Lock, R.B., and Ross, W.E. (1987) DNA Topoisomerases in Cancer Therapy, Anticancer Drug Des. 2, 151-164.
9. McPherson, J.P., and Goldenberg, G.J. (1998). Induction of Apoptosis by Deregulated Expression of DNA Topoisomerase IIα, Cancer Res. 58. 4519-4524.
10. Welsh, S.J., and Powis, G. (2003) Hypoxia Inducible Factor as a Cancer Drug Target, Curr. Cancer Drug Targets 3, 391-405.
11. Nagao, Y., Mustafa, J., Sano, S., Ochiai, M., Tazuko, T., and Shigeru, T. (1991) Different Mechanism of Action of Long Chain Fatty Acid Esters of Podophyllotoxin and Esters of Epipodophyllotoxin Against P388 Lymphocytic Leukemia in Mice, Med. Chem. Res. 1, 295-299.
12. Lie Ken Jie, M.S.F., Mustafa, J., and Pasha, M.K. (1999) Synthesis and Spectral Characteristics of Some Unusual Fatty Esters of Podophyllotoxin, Chem. Phys. Lipids 100, 165-170.
13. Sakurai, H., Miki, T., Imakura, Y., Shibuya, M., and Lee, K.H. (1991) Metal- and Photo-Induced Cleavage of DNA by Podophyllotoxin, Etoposide, and Their Related Compounds, Mol. Pharmacol. 40, 965-973.
14. Holm, C., Goto, T., Wang, J.C., and Botstein, D. (1985) DNA Topoisomerase II Is Required at the Time of Mitosis in Yeast, Cell 41, 553-563.
15. Watt, P.M., and Hickson, I.D. (1994) Structure and Function of Type II Topoisomerases, Biochem. J. 303, 681-695.
16. Wang, H.K., Morris-Natschke, S.L., and Lee, K.H. (1997) Recent Advances in the Discovery and Development of Topoisomerase Inhibitors as Antitumor Agents, Med. Res. Rev. 4, 367-425.
17. Larsen A.K., Escargueil, A.E., and Skladanowski, A. (2003) Catalytic Topoisomerase II Inhibitors in Cancer Therapy, Pharmacol. Ther. 99, 167-181.
18. Tanabe, K., Ikegami, Y., Ishida, R., and Andoh, T. (1991) Inhibition of Topoisomerase II by Antitumor Agents Bis(2,6-dioxopiperazine) Derivatives, Cancer Res. 51, 4903-4908.
19. Binder, C., and Hiddemann, W. (1994) Programmed Cell Death: Many Questions Still to Be Answered, Ann. Hematol. 69, 45-55.